SCA posts earnings growth thanks to cost control and price hikes

|
|

Although SCA’s financial results for the first quarter 2022 are lower than for the last quarter of 2021 due to revaluation of the company’s biological assets, the company’s earnings show a considerable increase against the same period last year.

Commenting on the first quarter results, the company says that i...

Read more

You can only use this article with a valid subscription and registration. Registered subscribers can access all articles after entering their user name and password.
- Ad -

Article topics
Article categories
- Ad -